Delivery Order SPE2DB22D2007-SPE2DB25FJ3KV
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $5,957.57 to AmerisourceBergen Drug Corp for MIEBO 100% eye drop solution (3ml) on August 7, 2025, with an ultimate completion date of August 8, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $3,817.41 to AmerisourceBergen Drug Corp for MIEBO 100% eye drop solution (3ML) on August 29, 2025, with an ultimate completion date of September 2, 2025. This firm fixed price contract represents a non-set-aside competitive award and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, fulfills...
- The Defense Logistics Agency awarded a $7,011.60 delivery order to AmerisourceBergen Drug Corp for MIEBO 100% eye drop solution (3 mL units) on June 2, 2025, with completion scheduled for June 3, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $8,490.73 to AmerisourceBergen Drug Corp on September 4, 2025, for MIEBO 100% eye drop solution in 3ml quantities. The contract is a firm fixed price delivery order with performance in Conshohocken, Pennsylvania, and an ultimate completion date of September 5, 2025. This award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's capability to compete for federal pharmaceutical procurement...
- The Defense Logistics Agency awarded a delivery order valued at $2,072.18 to AmerisourceBergen Drug Corp for MIEBO 100% eye drop solution (3ml) on July 24, 2025, with an ultimate completion date of July 25, 2025. This is a firm fixed-price contract with no set-aside designation, performed at the contractor's Conshohocken, Pennsylvania location. The award represents a small-value delivery order under the company's larger pharmaceutical supply vehicle with DLA. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $7,830.29 to AmerisourceBergen Drug Corp for MIEBO 100% Eye Drop 3ML on August 25, 2025, with an ultimate completion date of August 26, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the Conshohocken, Pennsylvania-based pharmaceutical distributor. The product will be delivered to the company's place of performance in Conshohocken, PA. This delivery order represents a...
- The Defense Logistics Agency awarded a delivery order valued at $8,723.79 to AmerisourceBergen Drug Corp for MIEBO 100% eye drop solution (3ML units) on July 23, 2025, with an ultimate completion date of July 24, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $1,636.68 delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for MIEBO 100% eye drop (3ml), with performance completed by July 28, 2025. The contract is structured as a firm fixed price delivery order with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly...
- The Defense Logistics Agency awarded a delivery order valued at $1,261.74 to AmerisourceBergen Drug Corp for MIEBO 100% eye drop solution (3ml) on September 11, 2025, with an ultimate completion date of September 12, 2025. This non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate office in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $2,880.44 to AmerisourceBergen Drug Corp for MIEBO 100% eye drop solution (3mL) on August 19, 2025, with completion expected by August 20, 2025. This competitively awarded, firm fixed-price delivery order was issued with no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger pharmaceutical...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB25FJ3KVDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,795.08 to AmerisourceBergen Drug Corp for MIEBO 100% eye drop solution (3ml units) on July 29, 2025, with completion scheduled for July 30, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical federal medical procurement vendor specializing in brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The parent IDC functions as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a broad range of pharmaceutical products and medical supplies to military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard. The contract award demonstrates the contractor's capability to meet federal procurement requirements through open competition and reflects DLA's ongoing strategy to maintain multiple qualified pharmaceutical vendors for critical medical supply needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.8k | 7/29/25 |